Rulong Shen

3.8k total citations
89 papers, 2.5k citations indexed

About

Rulong Shen is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Rulong Shen has authored 89 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 28 papers in Oncology and 21 papers in Surgery. Recurrent topics in Rulong Shen's work include Cervical Cancer and HPV Research (11 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Epigenetics and DNA Methylation (10 papers). Rulong Shen is often cited by papers focused on Cervical Cancer and HPV Research (11 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Epigenetics and DNA Methylation (10 papers). Rulong Shen collaborates with scholars based in United States, China and Taiwan. Rulong Shen's co-authors include Philippe Marchetti, Jin Li, Jianxin Gao, Zaibo Li, Xue‐Feng Bai, Sanford H. Barsky, Charles L. Shapiro, Huiling He, Albert de la Chapelle and Qingtao Yan and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Rulong Shen

86 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rulong Shen United States 27 1.2k 612 464 335 320 89 2.5k
P. Sivaramakrishna Rachakonda Germany 25 1.9k 1.6× 931 1.5× 577 1.2× 291 0.9× 305 1.0× 45 3.4k
Seok‐Hyung Kim South Korea 30 1.0k 0.9× 962 1.6× 402 0.9× 254 0.8× 398 1.2× 77 2.3k
Salvatore Travali Italy 29 1.8k 1.5× 904 1.5× 454 1.0× 269 0.8× 268 0.8× 96 2.9k
Christina H. Stuelten United States 24 1.5k 1.2× 880 1.4× 468 1.0× 454 1.4× 223 0.7× 38 3.1k
Marius Raica Romania 24 1.1k 0.9× 1.0k 1.7× 531 1.1× 365 1.1× 445 1.4× 223 2.8k
Shinichiro Nakamura Japan 30 897 0.7× 447 0.7× 410 0.9× 269 0.8× 280 0.9× 122 2.6k
Sébastien P. Tabruyn Belgium 26 1.3k 1.1× 587 1.0× 767 1.7× 276 0.8× 286 0.9× 36 2.4k
Douglas W. Strand United States 27 1.0k 0.8× 529 0.9× 501 1.1× 256 0.8× 192 0.6× 73 2.4k
Cecil R. Stockard United States 28 1.0k 0.8× 490 0.8× 203 0.4× 441 1.3× 411 1.3× 64 2.4k
Roland Kappler Germany 29 1.6k 1.3× 431 0.7× 399 0.9× 269 0.8× 251 0.8× 96 2.4k

Countries citing papers authored by Rulong Shen

Since Specialization
Citations

This map shows the geographic impact of Rulong Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rulong Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rulong Shen more than expected).

Fields of papers citing papers by Rulong Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rulong Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rulong Shen. The network helps show where Rulong Shen may publish in the future.

Co-authorship network of co-authors of Rulong Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Rulong Shen. A scholar is included among the top collaborators of Rulong Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rulong Shen. Rulong Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Rulong, Swati Satturwar, Peter Kobalka, et al.. (2024). Automated imaging analysis of Ki-67 immunohistochemistry on whole slide images of cell blocks from pancreatic neuroendocrine neoplasms. Journal of the American Society of Cytopathology. 13(3). 205–212. 4 indexed citations
3.
Ren, Rongqin, Somashekar G. Krishna, Wendy L. Frankel, et al.. (2020). Activation of the RAS pathway through uncommon BRAF mutations in mucinous pancreatic cysts without KRAS mutation. Modern Pathology. 34(2). 438–444. 22 indexed citations
4.
Chang, Long‐Sheng, Janet L. Oblinger, Sarah S. Burns, et al.. (2019). Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other Sarcomas. Molecular Cancer Therapeutics. 19(3). 731–741. 16 indexed citations
5.
Yung, Rex, Tao Cheng, Han Si, et al.. (2019). P1.09-12 In-Situ Hybridization Visual Scoring of Epigenetic Imprinting Genes Improves Early Diagnosis and Grading of Lung Cancers. Journal of Thoracic Oncology. 14(10). S500–S501.
6.
Hu, Zhiwei, Rulong Shen, Elizabeth L. McMichael, et al.. (2018). Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON. Cancer Immunology Research. 6(6). 671–684. 33 indexed citations
8.
Yao, Keluo, Rulong Shen, Anil V. Parwani, & Zaibo Li. (2018). A Comprehensive Study of Telecytology Using Robotic Digital Microscope and Single Z-Stack Digital Scan for Fine-Needle Aspiration-Rapid On-Site Evaluation. Journal of Pathology Informatics. 9(1). 49–49. 12 indexed citations
9.
Burns, Sarah S., Christine T. Dinh, Denise Yan, et al.. (2017). Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells. Molecular Cancer Therapeutics. 16(11). 2387–2398. 25 indexed citations
10.
Shen, Rulong, et al.. (2013). Florid diffuse peritoneal deciduosis mimicking carcinomatosis in a primigravida patient: a case report and review of the literature.. PubMed. 6(11). 2615–9. 13 indexed citations
11.
Zuo, Tao, Xun Lan, Yu‐I Weng, et al.. (2011). Epigenetic Silencing Mediated through Activated PI3K/AKT Signaling in Breast Cancer. Cancer Research. 71(5). 1752–1762. 52 indexed citations
12.
Wang, Qi‐En, Li Chen, Mengyao Liu, et al.. (2011). Correction: Germline Stem Cell Gene PIWIL2 Mediates DNA Repair through Relaxation of Chromatin. PLoS ONE. 6(11). 16 indexed citations
13.
Liu, James J., Rulong Shen, Li Chen, et al.. (2010). Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker.. PubMed. 3(4). 328–37. 80 indexed citations
14.
Yin, Detao, Lin Wang, Qingtao Yan, et al.. (2010). Association of the promoter methylation and protein expression of Fragile Histidine Triad (FHIT) gene with the progression of differentiated thyroid carcinoma.. PubMed. 3(5). 482–91. 14 indexed citations
15.
Wang, Lin, et al.. (2010). Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.. PubMed. 40(3). 267–72. 7 indexed citations
16.
Chen, Li, Quansheng Zhou, Rulong Shen, et al.. (2010). Identification of Piwil2-Like (PL2L) Proteins that Promote Tumorigenesis. PLoS ONE. 5(10). e13406–e13406. 68 indexed citations
17.
Lin, Huey‐Jen, Tao Zuo, Ching‐Hung Lin, et al.. (2008). Breast Cancer–Associated Fibroblasts Confer AKT1-Mediated Epigenetic Silencing of Cystatin M in Epithelial Cells. Cancer Research. 68(24). 10257–10266. 55 indexed citations
18.
Yang, Yali, Jingxiang Bai, Rulong Shen, et al.. (2008). Polo-like Kinase 3 Functions as a Tumor Suppressor and Is a Negative Regulator of Hypoxia-Inducible Factor-1α under Hypoxic Conditions. Cancer Research. 68(11). 4077–4085. 99 indexed citations
19.
Yan, Pearlly S., Chinnambally Venkataramu, Ashraf E.K. Ibrahim, et al.. (2006). Mapping Geographic Zones of Cancer Risk with Epigenetic Biomarkers in Normal Breast Tissue. Clinical Cancer Research. 12(22). 6626–6636. 153 indexed citations
20.
Marchetti, Philippe, Jin Li, & Rulong Shen. (2000). Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase.. PubMed. 60(17). 4767–70. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026